Triclofos Production Cost Reports

The report provides a detailed analysis essential for establishing a Triclofos production plant. It encompasses all critical aspects necessary for Triclofos production, including the cost of Triclofos production, Triclofos plant cost, Triclofos production costs, and the overall Triclofos production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Triclofos production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Triclofos is a sedative drug that is used for short term treatment of insomnia and for sedation before medical or diagnostic procedures. It is a prodrug that is converted in the body to trichloroethanol, which depresses the central nervous system and helps patients fall asleep faster and stay asleep longer.

But it is a relatively long half life that can cause next day drowsiness and is generally avoided for prolonged use or in patients with significant liver, kidney, or severe cardiac disease. It is used in adults and children to manage acute sleep disturbances, anxiety related sleep problems, and to sedate pediatric patients prior to procedures. Its common side effects include drowsiness, dizziness, nausea, vomiting, headache, and abdominal pain or gastrointestinal upset like diarrhoea.

The market for Triclofos is driven by the need for an affordable pediatric sedative-hypnotic for short-term insomnia management and procedural sedation. The presence of limited safer alternatives, along with ongoing third-party production, and inclusion in government hospital tenders for neonatal and pediatric care because of rising diagnostic procedures, boosts its demand. The development of oral solution formulations in developing regions with high pediatric sleep disorders fuels its market.

 Its overall expansion is limited by the replacement with modern non-barbiturate hypnotics in regulated markets. The industrial Triclofos procurement is influenced by hospital tenders via state medical corporations (like OSMCL, KMSCL, AIIMS) and Group Purchasing Organisations (GPOs). Also, quality packing and transport to prevent degradation, and the need for cost-effective generics for public health systems, affect its sourcing.

Raw Material for Triclofos Production

According to the Triclofos production plant project report, the key raw material used in the production of Triclofos includes Chloral-Sodium Borohydride-Polyphosphoric Acid.

Production Process of Triclofos

The extensive Triclofos production cost report consists of the following major industrial production process:

1. From Chloral, Sodium Borohydride, and Polyphosphoric Acid: The production process of Triclofos involves a reaction between chloral and sodium borohydride. First, chloral is reduced with sodium borohydride to produce 2,2,2-trichloroethanol. This alcohol is then esterified using polyphosphoric acid to form the dihydrogen phosphate ester, known as triclofos or 2,2,2-trichloroethyl dihydrogen phosphate. Finally, the ester is neutralised with an equimolar quantity of sodium hydroxide to yield triclofos sodium as the final product.

Triclofos, commonly formulated as triclofos sodium, has the molecular formula of C2H3Cl3NaO4P with a molecular weight of 251.36 g/mol. It appears as a white or almost white, odourless or almost odourless hygroscopic crystalline powder. It has one hydrogen bond donor, four acceptors, and high-water solubility (freely soluble), but only slight solubility in ethanol and practical insolubility in non-polar solvents. It is a monoalkyl phosphate prodrug hydrolysed in the liver to active trichloroethanol, with an estimated XLogP3-AA indicating moderate lipophilicity. It goes through pH-dependent hydrolysis (rapid under alkaline conditions) and atmospheric degradation by hydroxyl radicals (half-life of around 10 days). The compound is stable as a solid but requires protection from light and refrigeration in formulations like oral syrup.